Bayer Aims For Global Analgesic Market Dominance With Aleve, Aspirin
This article was originally published in The Tan Sheet
Executive Summary
The consolidation of the Aleve (naproxen sodium) franchise under one roof - and its pairing with Bayer Aspirin - appears to be a primary driver of Bayer's acquisition of Roche Consumer Health